Autologous peripheral blood-derived tolerogenic dendritic cells(Friends Of The Catholic University Of Korea)

N/A

Report date: 2022/11/20 20:50:24

Base Information

Drug NameAutologous peripheral blood-derived tolerogenic dendritic cells(Friends Of The Catholic University Of Korea)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapyCell and gene therapy > Cell therapy > Source of cells > Peripheral blood-derivedCell and gene therapy > Cell therapy > Donor > Autologous

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsMyocardial Infarction

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesFriends Of The Catholic University Of Korea Inc

China Registration ClassN/A

Develop Information

Active CompaniesFriends Of The Catholic University Of Korea Inc

Inactive CompaniesN/A

Active IndicationsMyocardial Infarction

Inactive IndicationsN/A

Other Information

ATC CodeN/A